Adding Intranasal to Oral Administration of an Ultra-rapid Near Universal Drug Regimen Accelerates Relapse-free Cure of Tuberculosis in Mice

By afschroeder • June 12, 2025

Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA. Adding Intranasal to Oral Administration of an Ultra-rapid Near Universal Drug Regimen Accelerates Relapse-free Cure of Tuberculosis in Mice. J Infect Dis. 2025 Jun 11:jiaf315. doi: 10.1093/infdis/jiaf315. Epub ahead of print. PMID: 40498595.

Tags: bedaquiline, delamanid, Infectious Diseases, intranasal therapy, Mycobacterium tuberculosis, Parabolic Response Surface, PRS Regimen V, Publications, relapse-free cure, Tuberculosis

Reducing excess antibiotic use with rapid tests to distinguish bacterial from nonbacterial causes of respiratory symptoms

Allan-Blitz LT, Klausner JD. Reducing excess antibiotic use with rapid tests to distinguish bacterial from nonbacterial causes of respiratory symptoms. Antimicrob Steward Healthc Epidemiol. 2026[...]

Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections

Allan-Blitz LT, Klausner JD. Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections. Antimicrob Steward Healthc Epidemiol.[...]

Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries

Moucheraud C, Li G, Ochieng E, Golub G, Phiri K, Chibaka S, Ganda G, Phiri S, Hyman S, Hoffman RM, Szilagyi PG, Dahlen A. Defining[...]